Analyst Ranking
Bottom 8%
#4574 out of 4937 analysts
Average Return
-1.59%
Win Rate
49%74 out of 152
Risk vs Reward
Poor
Good

Geoff Meacham's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Coherent CorpCOHR
+150.48%$26.29$65.85
2020-03-22 -
2021-03-23
Strong Buy
Checkmate Pharmaceuticals IncCMPI
+144.76%$4.29$10.50
2021-10-05 -
2022-05-27
Strong Buy
LianbioLIANY
+92.44%$4.22$0.32
2024-01-02 -
2024-03-18
Sell
Bridgebio Pharma IncBBIO
+90.12%$23.38$44.45
2024-06-24 -
2025-06-24
Strong Buy
Eli Lilly & CoLLY
+89.88%$425.77$808.45
2023-05-23 -
2024-05-23
Strong Buy

Geoff Meacham Analyst Color

Get additional color on Geoff Meacham's coverage of popular stocks

Geoff Meacham's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Bridgebio Pharma IncBBIO
6Strong Buy$54.00+16.20%Maintains
17 days ago
Protagonist Therapeutics IncPTGX
1Strong Buy$72.00+35.85%Initiates Coverage On
25 days ago
Newamsterdam Pharma Co NvNAMS
1Strong Buy$42.00+94.99%Initiates Coverage On
25 days ago
Arcellx IncACLX
1Strong Buy$110.00+59.47%Initiates Coverage On
25 days ago
Amylyx Pharmaceuticals IncAMLX
2Strong Buy$12.00+56.25%Initiates Coverage On
25 days ago
Acumen Pharmaceuticals IncABOS
4Strong Buy$4.00+185.71%Initiates Coverage On
25 days ago
Novavax IncNVAX
1Strong Sell$6.00-12.28%Initiates Coverage On
25 days ago
Avidity Biosciences IncRNA
6Strong Buy$75.00+138.47%Maintains
a month ago
Regeneron Pharmaceuticals IncREGN
9Strong Buy$650.00+14.49%Maintains
a month ago
Abbvie IncABBV
17Hold$205.00+6.52%Downgrades
2 months ago
Kymera Therapeutics IncKYMR
5Hold$44.00-1.08%Maintains
2 months ago
Ptc Therapeutics IncPTCT
8Hold$40.00-17.61%Upgrades
2 months ago
Biontech SeBNTX
2Strong Buy$140.00+24.01%Maintains
2 months ago
Neumora Therapeutics IncNMRA
3Sell$1.00-22.48%Downgrades
3 months ago
Moderna IncMRNA
7Hold$40.00+18.91%Initiates Coverage On
4 months ago
Kiniksa Pharmaceuticals International PLCKNSA
3Strong Buy$40.00+42.40%Initiates Coverage On
4 months ago
Apogee Therapeutics IncAPGE
2Strong Buy$95.00+149.08%Initiates Coverage On
4 months ago
89bio IncETNB
1Strong Buy$25.00+127.27%Initiates Coverage On
4 months ago
Biomarin Pharmaceutical IncBMRN
3Strong Buy$103.00+77.28%Maintains
5 months ago
Biogen IncBIIB
12Hold$145.00+8.04%Maintains
5 months ago
Amgen IncAMGN
9Hold$295.00-0.09%Maintains
5 months ago
Crispr Therapeutics AgCRSP
2Strong Buy$85.00+49.65%Maintains
6 months ago
Bioxcel Therapeutics IncBTAI
5Sell$4.00+103.05%Downgrades
6 months ago
Gilead Sciences IncGILD
6Strong Buy$125.00+14.01%Initiates Coverage On
8 months ago
Vertex Pharmaceuticals IncVRTX
3Strong Buy$575.00+22.64%Initiates Coverage On
8 months ago
Eli Lilly & CoLLY
10Strong Buy$1,100.00+38.71%Maintains
8 months ago
Lyell Immunopharma IncLYEL
3Sell$20.00+105.13%Downgrades
8 months ago
Tyra Biosciences IncTYRA
2Strong Buy$31.00+202.14%Upgrades
9 months ago
Turnstone Biologics CorpTSBX
2Strong Buy$10.00+2,617.39%Maintains
a year ago
Merck & Co IncMRK
6Strong Buy$145.00+73.94%Maintains
a year ago
Johnson & JohnsonJNJ
2Hold$170.00N/AMaintains
a year ago
Royalty Pharma PLCRPRX
2Strong Buy$38.00N/AMaintains
a year ago
Janux Therapeutics IncJANX
2Strong Buy$48.00N/AMaintains
a year ago
LianbioLIANY
1Sell$3.00N/ADowngrades
2 years ago
Bristol Myers Squibb CoBMY
7Hold$60.00N/ADowngrades
2 years ago
Igm Biosciences IncIGMS
2Hold$8.00N/ADowngrades
2 years ago
Vir Biotechnology IncVIR
2Hold$14.00N/ADowngrades
2 years ago
Curevac NvCVAC
4Sell$8.00N/AMaintains
2 years ago
Rani Therapeutics Holdings IncRANI
1Strong Buy$17.00N/AMaintains
2 years ago
Intercept Pharmaceuticals IncICPT
5Sell$14.00N/AMaintains
2 years ago
Pfizer IncPFE
6Hold$45.00N/AMaintains
2 years ago
Lenz Therapeutics IncLENZ
3Sell$2.00N/ADowngrades
2 years ago
Inovio Pharmaceuticals IncINO
4Sell$24.00N/ADowngrades
3 years ago
Omeros CorpOMER
2Hold$4.00N/ADowngrades
3 years ago
Vaxxinity IncVAXX
1Strong Buy$21.00N/AInitiates Coverage On
4 years ago
Checkmate Pharmaceuticals IncCMPI
1Strong Buy$7.00N/AUpgrades
4 years ago
Erasca IncERAS
1Strong Buy$28.00N/AInitiates Coverage On
4 years ago
Century Therapeutics IncIPSC
1Strong Buy$34.00N/AInitiates Coverage On
4 years ago
Y Mabs Therapeutics IncYMAB
3Strong Buy$56.00N/AUpgrades
4 years ago
Esperion Therapeutics IncESPR
2Hold$35.00N/ADowngrades
4 years ago
Seagen IncSGEN
6Strong BuyN/AN/AUpgrades
4 years ago
Galecto IncGLTO
1Strong Buy$525.00N/AInitiates Coverage On
5 years ago
Pmv Pharmaceuticals IncPMVP
1Strong Buy$42.00N/AInitiates Coverage On
5 years ago
Meiragtx Holdings PLCMGTX
1Strong Buy$20.00N/AReinstates
5 years ago
Sangamo Therapeutics IncSGMO
1Strong Buy$20.00N/AReinstates
5 years ago
Poseida Therapeutics IncPSTX
1Strong Buy$20.00N/AInitiates Coverage On
5 years ago
Puma Biotechnology IncPBYI
1Sell$9.00N/AReinstates
5 years ago
Regenxbio IncRGNX
1Strong Buy$60.00N/AReinstates
5 years ago
Genfit SaGNFT
1Sell$7.00N/AInitiates Coverage On
5 years ago
Eidos Therapeutics IncEIDX
1Hold$51.00N/AInitiates Coverage On
5 years ago
Coherent CorpCOHR
1Strong Buy$31.00N/AInitiates Coverage On
5 years ago
Alexion Pharmaceuticals IncALXN
1Hold$110.00N/ADowngrades
5 years ago
United Therapeutics CorpUTHR
2Strong Sell$95.00N/AMaintains
6 years ago
Myovant Sciences LtdMYOV
2Strong Buy$25.00N/AUpgrades
6 years ago
Dbv Technologies SaDBVT
3Hold$80.00N/ADowngrades
7 years ago
Gritstone Bio IncGRTSQ
1Strong Buy$25.00N/AInitiates Coverage On
7 years ago
Neurocrine Biosciences IncNBIX
2Strong Buy$135.00N/AMaintains
7 years ago
Prothena Corp Public Ltd CoPRTA
2Strong SellN/AN/ADowngrades
7 years ago
Zymeworks IncZYME
2HoldN/AN/AUpgrades
7 years ago
Ironwood Pharmaceuticals IncIRWD
1Hold$20.00N/AMaintains
7 years ago
Incyte CorpINCY
2Strong Buy$135.00N/AMaintains
7 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
2HoldN/AN/ADowngrades
7 years ago
Acceleron Pharma IncXLRN
2Strong Buy$54.00N/AMaintains
7 years ago
Celgene CorpCELG
4Strong BuyN/AN/AUpgrades
7 years ago
Alnylam Pharmaceuticals IncALNY
4Strong Buy$158.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.